BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 18026799)

  • 1. Prognostic significance of the immediate early response gene X-1 (IEX-1) expression in pancreatic cancer.
    Sasada T; Azuma K; Hirai T; Hashida H; Kanai M; Yanagawa T; Takabayashi A
    Ann Surg Oncol; 2008 Feb; 15(2):609-17. PubMed ID: 18026799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of IEX-1 expression in ovarian carcinoma.
    Han L; Geng L; Liu X; Shi H; He W; Wu MX
    Ultrastruct Pathol; 2011 Dec; 35(6):260-6. PubMed ID: 22085302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis.
    Masui T; Doi R; Koshiba T; Fujimoto K; Tsuji S; Nakajima S; Koizumi M; Toyoda E; Tulachan S; Ito D; Kami K; Mori T; Wada M; Noda M; Imamura M
    Clin Cancer Res; 2003 May; 9(5):1779-84. PubMed ID: 12738734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-level expression of Smad7 correlates with lymph node metastasis and poor prognosis in patients with pancreatic cancer.
    Wang P; Fan J; Chen Z; Meng ZQ; Luo JM; Lin JH; Zhou ZH; Chen H; Wang K; Xu ZD; Liu LM
    Ann Surg Oncol; 2009 Apr; 16(4):826-35. PubMed ID: 19165547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor-gamma and retinoid X receptor-alpha expression in pancreatic ductal adenocarcinoma: association with clinicopathological parameters, tumor proliferative capacity, and patients' survival.
    Giaginis C; Katsamangou E; Tsourouflis G; Zizi-Serbetzoglou D; Kouraklis G; Theocharis S
    Med Sci Monit; 2009 May; 15(5):BR148-56. PubMed ID: 19396032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin E expression and outcome in pancreatic ductal adenocarcinoma.
    Skalicky DA; Kench JG; Segara D; Coleman MJ; Sutherland RL; Henshall SM; Musgrove EA; Biankin AV
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1941-7. PubMed ID: 17035403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adhesion molecules as prognostic markers in pancreatic adenocarcinoma.
    Torer N; Kayaselcuk F; Nursal TZ; Yildirim S; Tarim A; Nòyan T; Karakayali H
    J Surg Oncol; 2007 Oct; 96(5):419-23. PubMed ID: 17874463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of pigment epithelium-derived factor decreases liver metastasis and correlates with favorable prognosis for patients with ductal pancreatic adenocarcinoma.
    Uehara H; Miyamoto M; Kato K; Ebihara Y; Kaneko H; Hashimoto H; Murakami Y; Hase R; Takahashi R; Mega S; Shichinohe T; Kawarada Y; Itoh T; Okushiba S; Kondo S; Katoh H
    Cancer Res; 2004 May; 64(10):3533-7. PubMed ID: 15150108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma.
    Magistrelli P; Coppola R; Tonini G; Vincenzi B; Santini D; Borzomati D; Vecchio F; Valeri S; Castri F; Antinori A; Nuzzo G; Caraglia M; Picciocchi A
    J Cell Biochem; 2006 Jan; 97(1):98-108. PubMed ID: 16173075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma.
    Liang JJ; Wang H; Rashid A; Tan TH; Hwang RF; Hamilton SR; Abbruzzese JL; Evans DB; Wang H
    Clin Cancer Res; 2008 Nov; 14(21):7043-9. PubMed ID: 18981001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma.
    Nitori N; Ino Y; Nakanishi Y; Yamada T; Honda K; Yanagihara K; Kosuge T; Kanai Y; Kitajima M; Hirohashi S
    Clin Cancer Res; 2005 Apr; 11(7):2531-9. PubMed ID: 15814630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clusterin expression predicts survival of invasive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy.
    Watari H; Ohta Y; Hassan MK; Xiong Y; Tanaka S; Sakuragi N
    Gynecol Oncol; 2008 Mar; 108(3):527-32. PubMed ID: 18177691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic implications of netrin-1 expression and its receptors in patients with adenocarcinoma of the pancreas.
    Link BC; Reichelt U; Schreiber M; Kaifi JT; Wachowiak R; Bogoevski D; Bubenheim M; Cataldegirmen G; Gawad KA; Issa R; Koops S; Izbicki JR; Yekebas EF
    Ann Surg Oncol; 2007 Sep; 14(9):2591-9. PubMed ID: 17549567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?
    Schnelldorfer T; Ware AL; Sarr MG; Smyrk TC; Zhang L; Qin R; Gullerud RE; Donohue JH; Nagorney DM; Farnell MB
    Ann Surg; 2008 Mar; 247(3):456-62. PubMed ID: 18376190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2 expression correlates with poor prognosis in pancreatic cancer.
    Juuti A; Louhimo J; Nordling S; Ristimäki A; Haglund C
    J Clin Pathol; 2006 Apr; 59(4):382-6. PubMed ID: 16467169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD74 is a novel prognostic factor for patients with pancreatic cancer receiving multimodal therapy.
    Nagata S; Jin YF; Yoshizato K; Tomoeda M; Song M; Iizuka N; Kitamura M; Takahashi H; Eguchi H; Ohigashi H; Ishikawa O; Tomita Y
    Ann Surg Oncol; 2009 Sep; 16(9):2531-8. PubMed ID: 19499276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma.
    Cohen SJ; Alpaugh RK; Palazzo I; Meropol NJ; Rogatko A; Xu Z; Hoffman JP; Weiner LM; Cheng JD
    Pancreas; 2008 Aug; 37(2):154-8. PubMed ID: 18665076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma.
    Infante JR; Matsubayashi H; Sato N; Tonascia J; Klein AP; Riall TA; Yeo C; Iacobuzio-Donahue C; Goggins M
    J Clin Oncol; 2007 Jan; 25(3):319-25. PubMed ID: 17235047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokine receptor CCR7 expression correlates with lymph node metastasis in pancreatic cancer.
    Nakata B; Fukunaga S; Noda E; Amano R; Yamada N; Hirakawa K
    Oncology; 2008; 74(1-2):69-75. PubMed ID: 18544997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survivin expression and its clinical significance in pancreatic cancer.
    Lee MA; Park GS; Lee HJ; Jung JH; Kang JH; Hong YS; Lee KS; Kim DG; Kim SN
    BMC Cancer; 2005 Oct; 5():127. PubMed ID: 16202147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.